Skip to main content

and
  1. Article

    Open Access

    Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma

    Despite advancements in understanding the pathophysiology of Multiple Myeloma (MM), the cause of rapid progressing disease in a subset of patients is still unclear. MM’s progression is facilitated by complex i...

    William Pilcher, Beena E. Thomas, Swati S. Bhasin in npj Genomic Medicine (2023)

  2. Article

    Open Access

    Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

    Multiple myeloma (MM) is a cancer of bone marrow (BM) plasma cells, which is increasingly treatable but still incurable. In 90% of MM patients, severe osteolysis results from pathological interactions between ...

    Deep Hathi, Chantiya Chanswangphuwana, Nicholas Cho in Scientific Reports (2022)

  3. Article

    Open Access

    A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

    Cancer patients undergo detrimental toxicities and ineffective treatments especially in the relapsed setting, due to failed treatment attempts. The development of a tool that predicts the clinical response of ...

    Kinan Alhallak, Amanda Jeske, Pilar de la Puente, Jennifer Sun in Scientific Reports (2021)

  4. No Access

    Article

    Utilization of radiation therapy in multiple myeloma: trends and changes in practice

    Plasma cell disorders including plasmacytomas and multiple myeloma (MM) are exquisitely radiosensitive, and thus, radiation therapy (XRT) is used effectively in their management. The role of XRT in the setting...

    Sikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, Zahara Kanji in Annals of Hematology (2021)

  5. Article

    Open Access

    Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

    Barbara Muz, Feda Azab, Mark Fiala, Justin King, Daniel Kohnen in Blood Cancer Journal (2019)

  6. Article

    Open Access

    A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

    Multiple myeloma (MM) is a disease of copy number variants (CNVs), chromosomal translocations, and single-nucleotide variants (SNVs). To enable integrative studies across these diverse mutation types, we devel...

    Brian S. White, Irena Lanc, Julie O’Neal, Harshath Gupta in Blood Cancer Journal (2018)

  7. Article

    Open Access

    Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

    Hematopoietic clones harboring specific mutations may expand over time. However, it remains unclear how different cellular stressors influence this expansion. Here we characterize clonal hematopoiesis after tw...

    Terrence N. Wong, Christopher A. Miller, Matthew R. M. Jotte in Nature Communications (2018)

  8. No Access

    Article

    Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

    Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation of plasma cells in the bone marrow and associated organ damage. Usually, patients with myeloma present with a single monoclona...

    Artur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska in Annals of Hematology (2017)

  9. Article

    Open Access

    Personalization of cancer treatment using predictive simulation

    The personalization of cancer treatments implies the reconsideration of a one-size-fits-all paradigm. This move has spawned increased use of next generation sequencing to understand mutations and copy number a...

    Nicole A Doudican, Ansu Kumar, Neeraj Kumar Singh in Journal of Translational Medicine (2015)

  10. No Access

    Article

    Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

    We conducted a phase I study using midostaurin (25 or 50 mg orally twice daily), all-trans retinoic acid (ATRA) and CLAG chemotherapy to target multiple pathways in relapsed/refractory AML. 10 patients received t...

    Giridharan Ramsingh, Peter Westervelt, Ali McBride in International Journal of Hematology (2014)

  11. No Access

    Article

    A topological approach to finding grids in calibration patterns

    This paper describes a technique for finding regular grids in the images of calibration patterns, a crucial step in calibrating cameras. Corner features located by a corner detector are connected using Delauna...

    Chang Shu, Alan Brunton, Mark Fiala in Machine Vision and Applications (2010)

  12. No Access

    Article

    Self-identifying patterns for plane-based camera calibration

    Determining camera calibration parameters is a time-consuming task despite the availability of calibration algorithms and software. A set of correspondences between points on the calibration target and the cam...

    Mark Fiala, Chang Shu in Machine Vision and Applications (2008)